- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Allecra Therapeutics GmbH
Headquarters: Weil am Rhein, Germany
Website: https://www.allecra.com/
Year Founded: 2013
Status: Private
BioCentury | Apr 3, 2024
Data Byte
Last minute flurry brings FDA’s first-quarter NME approvals to 10
Highlights include accelerated approval of first MASH therapy; plus Merck’s disease-modifying PAH therapy and Idorsia’s antihypertensive
BioCentury | Mar 13, 2024
Data Byte
NME approvals off to slow start in 2024
FDA has approved just three NMEs so far this year, down from 10 at this time in 2023
BioCentury | Aug 22, 2022
Emerging Company Profile
With Medicxi’s backing, Vaderis taking industry’s first shot at rare vascular disorder
European VC’s series A investment to fund start-up’s clinical evaluation of AKT inhibitor for hereditary hemorrhagic telangiectasia
BioCentury | Jan 25, 2020
Company News
Management tracks: Galapagos promotes Manto to CCO; plus Guardant, Horizon, Acceleron, Lilly, Krystal, Kura and more
Items per page:
1 - 10 of 15